We have concluded an advisory agreement with Professor Saito of the University of Southern California School of Medicine.

On the 15th December 2023, CytoPathfinder concluded Consulting Agreement with Dr. Takeshi Saito, professor of the Keck School of Medicine, University of Southern California.
He is an authority of liver disease, and support us to proceed research work in gene transduction and silencing in primary human hepatocyte.
He also support us to provide information and develop marketing and sales strategy in US as our advisor.